Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Thymic aplasia × Cyclosporine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 2 Thymic aplasia 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Immunologic Deficiency Syndromes 1

Interventions

Tacrolimus 1 Phlebotomy 1 Cyclosporins 1 Cyclosporine 1 Blood Specimen Collection 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed

11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡